研究
2019 研究業績・論文発表
論文
Watanabe M, Toyomura T, Wake H, Liu K, Teshigawara K, Takahashi H, Nishibori M, Mori S.
Differential contribution of possible pattern-recognition receptors to advanced glycation end product-induced cellular responses in macrophage-like RAW264.7 cells.
Biotechnol Appl Biochem. 2019 Oct 25.
終末糖化産物による細胞応答に対するパターン認識受容体についての検討
Gao S, Wake H, Gao Y, Wang D, Mori S, Liu K, Teshigawara K, Takahashi H, Nishibori M.
Histidine-rich glycoprotein ameliorates endothelial barrier dysfunction through regulation of NF-κB and MAPK signal pathway.
Br J Pharmacol. 2019 Aug;176(15):2808-2824.
HRGのBBD構造維持効果についての検討
Nishibori M, Mori S, Takahashi HK.
Anti-HMGB1 monoclonal antibody therapy for a wide range of CNS and PNS diseases.
J Pharmacol Sci. 2019 May;140(1):94-101.
中枢神経疾患に対する抗HMGB1抗体療法についての検討
Watanabe M, Toyomura T, Wake H, Liu K, Teshigawara K, Takahashi H, Nishibori M, Mori S.
The C-terminal region of tumor necrosis factor like weak inducer of apoptosis is required for interaction with advanced glycation end products.
Biotechnol Appl Biochem. 2019 Mar;66(2):254-260.
AGE/TNF-αによるアポド－シス誘導効果についての検討
Okuma Y, Wake H, Teshigawara K, Takahashi Y, Hishikawa T, Yasuhara T, Mori S, Takahashi HK, Date I, Nishibori M.
Anti-High Mobility Group Box 1 Antibody Therapy May Prevent Cognitive Dysfunction After Traumatic Brain Injury.
World Neurosurg. 2019 Feb;122:e864-e871.
抗HMGB1抗体による脳障害後の認知能改善効果についての検討